Oesophageal cancer, Secondary cancers, Stomach cancer
Results
Phase 2
This trial looked at giving more treatment after the first treatment for oesophageal cancer and stomach cancer. It was for people whose cancer couldn’t be removed with surgery. They had cancer of the:
food pipe (oesophageal cancer)
stomach (gastric cancer)
area where the food pipe meets the stomach (gastro oesophageal junction cancer)
People could join the trial between 2015 and 2024. The team published several papers in medical journals and presented results at conferences between 2021 and 2026. They plan to publish more results in the future.
Recruitment start: 1 May 2015
Recruitment end: 7 March 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cunningham
Clovis Oncology Inc
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)
MedImmune LLC
National Institute of Health and Care Research (NIHR)
The Royal Marsden NHS Foundation Trust
The Royal Marsden Cancer Charity
Last reviewed: 28 Jul 2026
CRUK internal database number: 11683